Scientists reduced blood clotting in mice with a blood disease called myeloproliferative neoplasm by inhibiting expression of a gene.
Northwestern Medicine scientists have uncovered new findings about a protein called SET1B, which could offer a novel approach to treating triple-negative breast cancer.
Northwestern Medicine scientists identified a complex regulatory system that keeps cells functioning when their oxygen supply is cut off.
Patients with advanced neuroendocrine tumors had a similar quality of life while on a newly approved chemotherapy drug, as compared to patients receiving a placebo, according to a Northwestern Medicine study.
A team of scientists has identified the genetic drivers of diffuse large B-cell lymphoma, the most common type of blood cancer, and determined the genes’ clinical significance.
Small RNA molecules can trigger a mechanism hidden in every cell, forcing it to commit suicide, according to a new Northwestern Medicine study, the first to identify molecules that trigger such a fail-safe mechanism.
Women with invasive breast cancer who were treated with an aggressive lymph node removal saw no survival benefit compared to those who received a less invasive procedure, according to a new clinical trial.
A new Northwestern Medicine study reveals surprising findings about an enzyme called Set1A and its function in embryonic stem cell self-renewal and differentiation.
A comprehensive genomic analysis of the most common kidney cancer in children – found genetic mutations involving two distinct processes, potentially providing new opportunities for future treatments.
Northwestern Medicine research has explained the mechanism behind ‘pauses’ in transcription, which has implications for future cancer therapies.